Targeted Cancer Therapy
Generics in this class (19)
Axitinib
3 brands
Bevacizumab
25 brands
Bortezomib
6 brands
Cetuximab
4 brands
Crizotinib
10 brands
Dasatinib
35 brands
Erlotinib
36 brands
Gefitinib
12 brands
Ibrutinib
16 brands
Imatinib Mesylate
25 brands
Infliximab
2 brands
Nilotinib
13 brands
Olaparib
30 brands
Pertuzumab
2 brands
Regorafenib Monohydrate
4 brands
Ribociclib
5 brands
Sorafenib Tosylate
10 brands
Sunitinib
20 brands
Trastuzumab
13 brands
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before taking, changing, or stopping any medicine.